Search research articles
Contact Us
Filters
Showing results (291-300 of 384) with videos related to
Page
of 39
Sort By:
Acta Haematologica
|
September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia
Muhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 4, 2008
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
Zejuan Li, Jun Lu, Miao Sun, et al.
Transplantation and Cellular Therapy
|
December 16, 2022
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy
Alexander E Perl, Richard A Larson, Nikolai A Podoltsev, et al.
Blood
|
February 26, 2025
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study
Joshua F Zeidner, David A Sallman, Christian Récher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 9, 2005
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study
Guido Marcucci, Claudia D Baldus, Amy S Ruppert, et al.
Blood Neoplasia
|
June 2, 2025
Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial
Timothy S Pardee, Bayard L Powell, Richard A Larson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 26, 2019
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy
Zachariah DeFilipp, Anjali S Advani, Veronika Bachanova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
Guido Marcucci, Kati Maharry, Yue-Zhong Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2010
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
Sebastian Schwind, Kati Maharry, Michael D Radmacher, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 8, 2012
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia
Xi Jiang, Hao Huang, Zejuan Li, et al.
Page
of 39
Search research articles
Search
Showing results (291-300 of 384) with videos related to
Sort By:
Page
of 39
Acta Haematologica
|
September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia
Muhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 4, 2008
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
Zejuan Li, Jun Lu, Miao Sun, et al.
Transplantation and Cellular Therapy
|
December 16, 2022
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy
Alexander E Perl, Richard A Larson, Nikolai A Podoltsev, et al.
Blood
|
February 26, 2025
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study
Joshua F Zeidner, David A Sallman, Christian Récher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 9, 2005
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study
Guido Marcucci, Claudia D Baldus, Amy S Ruppert, et al.
Blood Neoplasia
|
June 2, 2025
Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial
Timothy S Pardee, Bayard L Powell, Richard A Larson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 26, 2019
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy
Zachariah DeFilipp, Anjali S Advani, Veronika Bachanova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
Guido Marcucci, Kati Maharry, Yue-Zhong Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2010
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
Sebastian Schwind, Kati Maharry, Michael D Radmacher, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 8, 2012
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia
Xi Jiang, Hao Huang, Zejuan Li, et al.
Page
of 39